FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2531242829> ?p ?o ?g. }

• W2531242829 abstract "Abstract Objectives: We evaluated the association of the primary area of residence (urban vs. rural) and treatment (trt) provider (university-based vs. community-based) with overall survival in patients with lymphoma, and determined if there are patient subgroups that could benefit from better coordination of care. Methods: We performed a population-based study in 2,330 patients with centrally confirmed lymphoma from Nebraska and surrounding states reported to the Nebraska Lymphoma Study Group between 1982 and 2006. Patient residential ZIP codes at the time to trt were used to determine rural/urban designation, household income and distance to trt center; while trt providers were categorized into university-based or community based. Multivariate analyses were used to group patients into risk levels based on 8 factors found to be associated with survival at the time of trt (age, performance score, Ann Arbor stage, presence of B symptoms, LDH levels, tumor bulk, nodal and extranodal involvement). The following categories were identified: low-risk (1–3 factors), intermediate risk (4–5 factors), and high-risk (≥6 factors). Cox proportional regression analyses, stratified by type of lymphoma (low-grade NHL, high-grade NHL and Hodgkin) were used to evaluate the association between place of residence and trt provider with overall survival. Results: Among urban residents, 321 (14%) were treated by university-based providers (UUB) and 816 (35%) were treated by community-based providers (UCB). Among rural residents, 332 (14%) were treated by university-based providers (RUB) and 861 (37%) were treated by community-based providers (RCB). Patients from rural areas were more likely to be older and Caucasian, with a lower median household income, greater travel distance to seek trt, and more likely to have high-risk disease when compared to patients from urban areas. In multivariate analysis, using all patients regardless of risk level, the relative risk of death (RR) among UUB, UCB and RUB was not statistically different. However, RCB had a higher risk of death RR 1.37, 95% CI 1.14–1.65, p=0.01; RR 1.18, 95% CI 1.04–1.33, p<0.01; and RR 1.26, 95% CI 1.06–1.49, p=0.01 when compared with UUB, UCB and RUB, respectively. This association remained true in both low- and intermediate-risk patients. Among high-risk patients, both RUB and RCB were at higher risk of death when compared with UUB or UCB, while UCB were not different from UUB. We found no differences in progression-free survival according to place of residence and trt provider. The use of stem cell transplantation was significantly higher in patients coming from urban and rural areas treated by university-based providers (UUB 19%, RUB 16%) compared to urban and rural patients treated by community-based providers (UCB 11%, RCB 10%, p < 0.01). Patients from rural areas (RUB and RCB) were slightly less likely to die from lymphoma-related causes than patients from urban areas (75% versus 80%, p=0.04). Conclusion: Overall survival in patients with lymphoma is inferior in patients coming from rural areas. This relationship varies according to treatment provider and pretreatment risk levels. Further studies in patients from rural areas are needed to understand how coordination of care is carried to design appropriate interventions that may improve the disparity noted." @default.
• W2531242829 created "2016-10-21" @default.
• W2531242829 creator A5015628512 @default.
• W2531242829 creator A5022164102 @default.
• W2531242829 creator A5025748721 @default.
• W2531242829 creator A5038555959 @default.
• W2531242829 creator A5061471602 @default.
• W2531242829 creator A5064436224 @default.
• W2531242829 creator A5072480385 @default.
• W2531242829 creator A5080373697 @default.
• W2531242829 creator A5027285481 @default.
• W2531242829 date "2008-11-16" @default.
• W2531242829 modified "2023-09-28" @default.
• W2531242829 title "Survival Disparities in Patients with Lymphoma According to Place of Residence and Treatment Provider: A Population-Based Study" @default.
• W2531242829 doi "https://doi.org/10.1182/blood.v112.11.874.874" @default.
• W2531242829 hasPublicationYear "2008" @default.
• W2531242829 type Work @default.
• W2531242829 sameAs 2531242829 @default.
• W2531242829 citedByCount "0" @default.
• W2531242829 crossrefType "journal-article" @default.
• W2531242829 hasAuthorship W2531242829A5015628512 @default.
• W2531242829 hasAuthorship W2531242829A5022164102 @default.
• W2531242829 hasAuthorship W2531242829A5025748721 @default.
• W2531242829 hasAuthorship W2531242829A5027285481 @default.
• W2531242829 hasAuthorship W2531242829A5038555959 @default.
• W2531242829 hasAuthorship W2531242829A5061471602 @default.
• W2531242829 hasAuthorship W2531242829A5064436224 @default.
• W2531242829 hasAuthorship W2531242829A5072480385 @default.
• W2531242829 hasAuthorship W2531242829A5080373697 @default.
• W2531242829 hasConcept C126322002 @default.
• W2531242829 hasConcept C129047720 @default.
• W2531242829 hasConcept C142724271 @default.
• W2531242829 hasConcept C144024400 @default.
• W2531242829 hasConcept C149923435 @default.
• W2531242829 hasConcept C2776269092 @default.
• W2531242829 hasConcept C2779338263 @default.
• W2531242829 hasConcept C2908647359 @default.
• W2531242829 hasConcept C50382708 @default.
• W2531242829 hasConcept C512399662 @default.
• W2531242829 hasConcept C71924100 @default.
• W2531242829 hasConcept C74909509 @default.
• W2531242829 hasConcept C99454951 @default.
• W2531242829 hasConceptScore W2531242829C126322002 @default.
• W2531242829 hasConceptScore W2531242829C129047720 @default.
• W2531242829 hasConceptScore W2531242829C142724271 @default.
• W2531242829 hasConceptScore W2531242829C144024400 @default.
• W2531242829 hasConceptScore W2531242829C149923435 @default.
• W2531242829 hasConceptScore W2531242829C2776269092 @default.
• W2531242829 hasConceptScore W2531242829C2779338263 @default.
• W2531242829 hasConceptScore W2531242829C2908647359 @default.
• W2531242829 hasConceptScore W2531242829C50382708 @default.
• W2531242829 hasConceptScore W2531242829C512399662 @default.
• W2531242829 hasConceptScore W2531242829C71924100 @default.
• W2531242829 hasConceptScore W2531242829C74909509 @default.
• W2531242829 hasConceptScore W2531242829C99454951 @default.
• W2531242829 hasLocation W25312428291 @default.
• W2531242829 hasOpenAccess W2531242829 @default.
• W2531242829 hasPrimaryLocation W25312428291 @default.
• W2531242829 hasRelatedWork W1754777876 @default.
• W2531242829 hasRelatedWork W1851246756 @default.
• W2531242829 hasRelatedWork W1876096351 @default.
• W2531242829 hasRelatedWork W1956179020 @default.
• W2531242829 hasRelatedWork W2055942060 @default.
• W2531242829 hasRelatedWork W2346510664 @default.
• W2531242829 hasRelatedWork W2419163947 @default.
• W2531242829 hasRelatedWork W2551930302 @default.
• W2531242829 hasRelatedWork W2578579700 @default.
• W2531242829 hasRelatedWork W2587930936 @default.
• W2531242829 hasRelatedWork W2744016857 @default.
• W2531242829 hasRelatedWork W2756109671 @default.
• W2531242829 hasRelatedWork W2915062130 @default.
• W2531242829 hasRelatedWork W2983234492 @default.
• W2531242829 hasRelatedWork W3013788339 @default.
• W2531242829 hasRelatedWork W3033219417 @default.
• W2531242829 hasRelatedWork W3047947652 @default.
• W2531242829 hasRelatedWork W3096246918 @default.
• W2531242829 hasRelatedWork W3140646279 @default.
• W2531242829 hasRelatedWork W3198355152 @default.
• W2531242829 isParatext "false" @default.
• W2531242829 isRetracted "false" @default.
• W2531242829 magId "2531242829" @default.
• W2531242829 workType "article" @default.